These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32340978)

  • 1. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Jan; 80(1):e3. PubMed ID: 32340978
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.
    Gupta L; Misra DP; Agarwal V; Balan S; Agarwal V
    Ann Rheum Dis; 2021 Jan; 80(1):e1. PubMed ID: 32299795
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.
    Ouédraogo DD; Tiendrébéogo WJS; Kaboré F; Ntsiba H
    Clin Rheumatol; 2020 Jul; 39(7):2069-2075. PubMed ID: 32472461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
    Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
    Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
    Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
    Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
    Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
    Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
    Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
    Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
    Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
    Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
    Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
    Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
    Saldarriaga Rivera LM; Fernández Ávila D; Bautista Molano W; Jaramillo Arroyave D; Bautista Ramírez AJ; Díaz Maldonado A; Hernán Izquierdo J; Jáuregui E; Latorre Muñoz MC; Restrepo JP; Segura Charry JS
    Reumatol Clin (Engl Ed); 2020; 16(6):437-446. PubMed ID: 32800760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine A; Soussan I; Nadiri K; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021 Aug; 17(3):318-326. PubMed ID: 33371850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Feb; 80(2):e15. PubMed ID: 32414805
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.
    Gremese E; Ferraccioli ES; Alivernini S; Tolusso B; Ferraccioli G
    Eur J Clin Invest; 2020 Sep; 50(9):e13342. PubMed ID: 32645207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.